Contracts › 36C25226P0111
36C25226P0111: Lenalidomide/Revlimid Dose
Awarded to Exelan Pharmaceuticals Inc by Department of Veterans Affairs.
$2.6Mobligated
$2.6Mpotential value
14 December 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 36C25226P0111 |
|---|---|
| Awardee | Exelan Pharmaceuticals Inc |
| Awarding agency | Department of Veterans Affairs |
| Awarding office | 252-NETWORK CONTRACT OFFICE 12 (36C252) |
| NAICS | 325412 Pharmaceutical Preparation Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | FL |
| Offers received | 2 |
| Period of performance | 15 December 2025 to 14 December 2026 |
| Potential end | 14 December 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325412 contracts · All expiring contracts · USASpending record